Viewing Study NCT01336920


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-01-22 @ 11:30 AM
Study NCT ID: NCT01336920
Status: COMPLETED
Last Update Posted: 2023-09-15
First Post: 2011-03-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Sponsor: University of Nebraska
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module